Molecules · 2022 · 28 citations · 46 references
PharmacyMolecular PharmaceuticsPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryAntibody ConjugatesCancer Drug DeliveryCancer NanomedicineNanomaterials For Drug DeliveryNanomedicineNanoparticle FormulationsAnticancer ActivityAnticancer ChemotherapyCytotoxicity AssaysFolate ReceptorsMagnetic Nanoparticle Drug CarriersMagnetic Nanoparticle Drug DeliveryMagnetic NanoparticlesNanoparticle Cytotoxicity
Therapeutic effects of anticancer medicines can be improved by targeting the specific receptors on cancer cells. Folate receptor (FR) targeting with antibody (Ab) is an effective tool to deliver anticancer drugs to the cancer cell. In this research project, a novel formulation of targeting drug delivery was designed, and its anticancer effects were analyzed. Folic acid-conjugated magnetic nanoparticles (MNPs) were used for the purification of folate receptors through a novel magnetic affinity purification method. Antibodies against the folate receptors and methotrexate (MTX) were developed and characterized with enzyme-linked immunosorbent assay and Western blot. Targeting nanomedicines (MNP-MTX-FR Ab) were synthesized by engineering the MNP with methotrexate and anti-folate receptor antibody (anti-FR Ab). The cytotoxicity of nanomedicines on HeLa cells was analyzed by calculating the % age cell viability. A fluorescent study was performed with HeLa cells and tumor tissue sections to analyze the binding efficacy and intracellular tracking of synthesized nanomedicines. MNP-MTX-FR Ab demonstrated good cytotoxicity along all the nanocomposites, which confirms that the antibody-coated medicine possesses the potential affinity to destroy cancer cells in the targeted drug delivery process. Immunohistochemical approaches and fluorescent study further confirmed their uptake by FRs on the tumor cells' surface in antibody-mediated endocytosis. The current approach is a useful addition to targeted drug delivery for better management of cancer therapy along with immunotherapy in the future.
46
Nanoparticles: Properties, applications and toxicities
Ibrahim Khan, Ibrahim Khan, Khalid Saeed et al. · Arabian Journal of Chemistry · 2017 · 6.8K citations · Full text
Cancer statistics for the year 2020: An overview
Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · International Journal of Cancer · 2021 · 5.7K citations · Full text